October 21, 2015October 21, 2015

Scientist Publishes New Review on Sustained Release Naltrexone/Bupropion for Obesity

News

US Endocrinology, a peer-reviewed journal of research relating to the endocrine system, recently published a focused review on the positive effects of a relatively new combination treatment for obesity. The report ... Read more

January 6, 2015January 6, 2015

Mysimba™ By Orexigen Receives Positive CHMP Opinion and Recommendation For Weight Management In EU

News

Orexigen Therapeutics announced that the Committee for Medicinal Products For Human Use (CHMP) of the European Medicines Agency (EMA) recommends Mysimba™ (naltrexone HCl / bupropion HCl prolonged release) for centralized marketing authorization ... Read more